{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:10:27Z","timestamp":1761052227746,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.bcmd.2016.01.001","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T03:15:26Z","timestamp":1452136526000},"page":"110-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Capricious CALR mutated clones in myeloproliferative neoplasms"],"prefix":"10.1016","volume":"57","author":[{"given":"Karl","family":"Haslam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eibhlin","family":"Conneally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E.","family":"Langabeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2016.01.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2015.64","article-title":"Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis","volume":"5","author":"Barbui","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.bcmd.2016.01.001_bb0010","article-title":"Next-generation deep sequencing detects multiple clones of CALR mutations in patients with BCR-ABL1 negative MPN","author":"Jeromin","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2016.01.001_bb0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bcmd.2015.07.011","article-title":"Calreticulin mutation burden \u2014 is it a stable clone in patients with essential thrombocythemia and myelofibrosis","volume":"55","author":"Shuly","year":"2015","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2016.01.001_bb0020","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/bjh.12904","article-title":"Assessment of CALR mutations in myelofibrosis patients, post-allogeneic stem cell transplantation","volume":"166","author":"Haslam","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.01.001_bb0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.leukres.2014.11.019","article-title":"Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms","volume":"39","author":"Jones","year":"2015","journal-title":"Leuk Res."},{"key":"10.1016\/j.bcmd.2016.01.001_bb0030","doi-asserted-by":"crossref","first-page":"e0141010","DOI":"10.1371\/journal.pone.0141010","article-title":"Calreticulin mutations in myeloproliferative neoplasms: comparison of three diagnostic methods","volume":"10","author":"Park","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcmd.2016.01.001_bb0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/ejh.12578","article-title":"Molecular diagnostics of myeloproliferative neoplasms","volume":"95","author":"Langabeer","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2016.01.001_bb0040","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2015-07-659060","article-title":"Clinical and molecular response to interferon alpha therapy in essential thrombocythemia patients with CALR mutations","volume":"126","author":"Verger","year":"2015","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979616300018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:32:38Z","timestamp":1761049958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979616300018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":8,"alternative-id":["S1079979616300018"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.01.001","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Capricious CALR mutated clones in myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2016.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}